SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Smith RA, Cokkinides V, Brawley OW. Cancer screening in the United States, 2009: a review of current American Cancer Society guidelines and issues in cancer screening. CA Cancer J Clin. 2009;59:27-41.
  • 2
    Smith RA, Cokkinides V, Brooks D, Saslow D, Brawley OW. Cancer screening in the United States, 2010: a review of current American Cancer Society guidelines and issues in cancer screening. CA Cancer J Clin. 2010;60:99-119.
  • 3
    American College of Obstetricians-Gynecologists. Practice bulletin no. 122: breast cancer screening. Obstet Gynecol. 2011;118:372-382.
  • 4
    US Preventive Services Task Force. Screening for breast cancer: US Preventive Services Task Force recommendation statement. Ann Intern Med. 2009;151:716-726, W236.
  • 5
    World Health Organization. Breast Cancer: Prevention and Control. Geneva, Switzerland: World Health Organization; 2013. Available at: http://www.who.int/cancer/detection/breastcancer/en/index.html. Accessed April 12, 2013.
  • 6
    US Preventive Services Task Force. Screening for skin cancer: US Preventive Services Task Force recommendation statement. Ann Intern Med. 2009;150:188-193.
  • 7
    Goldberg MS, Doucette JT, Lim HW, Spencer J, Carucci JA, Rigel DS. Risk factors for presumptive melanoma in skin cancer screening: American Academy of Dermatology National Melanoma/Skin Cancer Screening Program experience 2001-2005. J Am Acad Dermatol. 2007;57:60-66.
  • 8
    Field MJ, Lawrence RL, Zwanziger L, eds; Committee on Medicare Coverage Extensions, Division of Health Care Services, Institute of Medicine. Extending Medicare Coverage for Preventive and Other Services. Washington, DC: National Academy Press; 1991. Available at: http://www.nap.edu/openbook.php?isbn=0309068894. Accessed April 12, 2013.
  • 9
    Carter HB, Albertsen PC, Barry MJ, et al. Early detection of prostate cancer: AUA Guideline. J Urol. 2013;190:419-426.
  • 10
    Greene KL, Albertsen PC, Babaian RJ, et al. Prostate specific antigen best practice statement: 2009 update. J Urol. 2013;189:S2-S11.
  • 11
    Moyer VA;US Preventive Services Task Force. Screening for prostate cancer: US Preventive Services Task Force recommendation statement. Ann Intern Med. 2012;157:120-134.
  • 12
    Committee on Gynecologic Practice. Committee opinion no. 534: well-woman visit. Obstet Gynecol. 2012;120:421-424.
  • 13
    Whitlock EP, Vesco KK, Eder M, Lin JS, Senger CA, Burda BU. Liquid-based cytology and human papillomavirus testing to screen for cervical cancer: a systematic review for the US Preventive Services Task Force. Ann Intern Med. 2011;155:687-697, W214-W215.
  • 14
    Moyer VA;US Preventive Services Task Force. Screening for ovarian cancer: US Preventive Services Task Force reaffirmation recommendation statement. Ann Intern Med. 2012;157:900-904.
  • 15
    National Ambulatory Health Care/National Hospital Ambulatory Medical Care Survey (NAMCS/NHAMCS).About the Ambulatory Health Care Surveys. Available at: http://www.cdc.gov/nchs/ahcd/about_ahcd.htm. Accessed April 30, 2013.
  • 16
    National Ambulatory Health Care/National Hospital Ambulatory Medical Care Survey NAMCS/NHAMCS.Questionnaires, Datasets, and Related Documentation. Available at: http://www.cdc.gov/nchs/ahcd/ahcd_questionnaires.htm. Accessed April 30, 2013.
  • 17
    Ward E, Jemal A, Cokkinides V, et al. Cancer disparities by race/ethnicity and socioeconomic status. CA Cancer J Clin. 2004;54:78-93.
  • 18
    Simard EP, Fedewa S, Ma J, Siegel R, Jemal A. Widening socioeconomic disparities in cervical cancer mortality among women in 26 states, 1993-2007. Cancer. 2012;118:5110-5116.
  • 19
    Patel VB, Nahar R, Murray B, Salner AL. Exploring implications of Medicaid participation and wait times for colorectal screening on early detection efforts in Connecticut—a secret-shopper survey. Conn Med. 2013;77:197-203.
  • 20
    Kempe KL, Larson RS, Shetterley S, Wilkinson A. Breast cancer screening in an insured population: whom are we missing? Perm J. 2013;17:38-44.
  • 21
    Harper, S.Lynch J, Meersman SC, Breen N, Davis WW, Reichman MC. Trends in area-socioeconomic and race-ethnic disparities in breast cancer incidence, stage at diagnosis, screening, mortality, and survival among women ages 50 years and over (1987-2005). Cancer Epidemiol Biomarkers Prev. 2009;18:121-131.
  • 22
    Baquet CR, Commiskey P. Socioeconomic factors and breast carcinoma in multicultural women. Cancer. 2000;88:1256-1264.
  • 23
    Wen CP, Tsai SP, Chung W-SI. A 10-year experience with universal health insurance in Taiwan: measuring changes in health and health disparity. Ann Intern Med. 2008;148:258-267.
  • 24
    Mulligan CR, Meram AD, Proctor CD, Wu H, Zhu K, Marroqi AJ. Unlimited access to care: effect on racial disparity and prognostic factors in lung cancer. Cancer Epidemiol Biomarkers Prev. 2006;15:25-31.
  • 25
    Patel N, Bae S, Singh KP. Association between utilization of preventive services and health insurance status: findings from the 2008 Behavioral Risk Factor Surveillance System. Ethn Dis. 2010;20:142-147.
  • 26
    Watts L, Joseph N, Velazquez A, et al. Understanding barriers to cervical cancer screening among Hispanic women. Am J Obstet Gynecol. 2009;201:199.e1-199.e8.
  • 27
    Erickson BK, Zhang B, Straughn JM Jr. Screening behaviors and cultural barriers in women with newly diagnosed cervical cancer [published online ahead of print April 16, 2013]. J Low Genit Tract Dis. 2013.
  • 28
    Armstrong K, Putt M, Halbert CH, et al. Prior experiences of racial discrimination and racial differences in health care system distrust. Med Care. 2013;51:144-150.
  • 29
    Clegg LX, Beichman ME, Miller BA, et al. Impact of socioeconomic status on cancer incidence and stage at diagnosis: selected findings from the Surveillance, Epidemiology, and End Results: National Longitudinal Mortality Study. Cancer Causes Control. 2000;20:417-435.
  • 30
    Powell IJ. Prostate cancer and African-American men. Oncology (Williston Park). 1997;11:599-605; discussion 606-615 passim.
  • 31
    Martin DN, Starks AM, Ambs S. Biological determinants of health disparities in prostate cancer. Curr Opin Oncol. 2013;25:235-241.
  • 32
    Miller JW, King JB, Joseph DA, Richardson LC;Centers for Disease Control and Prevention (CDC). Breast cancer screening among adult women—Behavioral Risk Factor Surveillance System, United States, 2010. MMWR Morb Mortal Wkly Rep. 2013;61(suppl):46-50.
  • 33
    Grabowski DC. Medicare and Medicaid: conflicting incentives for long-term care. Milbank Q. 2007;85:579-610.
  • 34
    Hsia J, Kemper E, Kiefe C, et al. The importance of health insurance as a determinant of cancer screening: evidence from the Women's Health Initiative. Prev Med. 2000;31:261-270.
  • 35
    Brooks DD, Wolf A, Smith RA, Dash C, Guessous I. Prostate cancer screening 2010: updated recommendations from the American Cancer Society. J Natl Med Assoc. 2010;102:423-442.
  • 36
    Wolf AM, Wender RC, Etzioni RB, et al.American Cancer Society Prostate Cancer Advisory Committee. American Cancer Society guideline for the early detection of prostate cancer: update 2010. CA Cancer J Clin. 2010;60:70-98.
  • 37
    Kale MS, Bishop TF, Federman AD, Keyhani S. Trends in the overuse of ambulatory health care services in the United States. JAMA Intern Med. 2013;173:142-148.
  • 38
    Miller AB, To T, Baines CJ, Wall C. Canadian National Breast Screening Study-2: 13-year results of a randomized trial in women aged 50-59 years. J Natl Cancer Inst. 2000;92:1490-1499.
  • 39
    Chiarelli AM, Maipruz V, Brown P, Theriault M, Shumak R, Mai V. The contribution of clinical breast examination to the accuracy of breast screening. J Natl Cancer Inst. 2009;101:1236-1243.
  • 40
    Nelson HD, Tyne K, Naik A, et al. Screening for breast cancer: an update for the US Preventive Services Task Force. Ann Intern Med. 2009;151:727-737, W237-W242.
  • 41
    Smith RA, Brooks D, Cokkinides V, Saslow D, Brawley OW. Cancer screening in the United States, 2013: a review of current American Cancer Society guidelines, current issues in cancer screening, and new guidance on cervical cancer screening and lung cancer screening. CA Cancer J Clin. 2013;63:88-105.
  • 42
    Westhoff CL, Jones HE, Guiahi M. Do new guidelines and technology make the routine pelvic examination obsolete? J Womens Health (Larchmt). 2011;20:5-10.
  • 43
    Henderson JT, Harper CC, Gutin S, Saraiya M, Chapman J, Sawaya GF. Routine bimanual pelvic examinations: practices and beliefs of US obstetrician-gynecologists. Am J Obstet Gynecol. 2013;208:109.e1-109.e17.
  • 44
    Domar AD. Psychological aspects of the pelvic exam: individual needs and physician involvement. Women Health. 1985;10:75-90.
  • 45
    Simard EP, Ward EM, Siegel R, Jemal A. Cancers with increasing incidence trends in the United States: 1999 through 2008 [published online ahead of print January 4, 2012]. CA Cancer J Clin. 2012.
  • 46
    Little EG, Eide MJ. Update on the current state of melanoma incidence. Dermatol Clin. 2012;30:355-361.
  • 47
    Wolff T, Tai E, Miller T. Screening for Skin Cancer: An Update of the Evidence for the US Preventive Services Task Force. Rockville, MD: Agency for Healthcare Research and Quality; 2009. Available at: http://www.ncbi.nlm.nih.gov/books/NBK34051/. Accessed April 30, 2013.
  • 48
    Petitti DB, Teutsch SM, Barton MD, et al. Update on the methods of the US Preventive Services Task Force: insufficient evidence. Ann Intern Med. 2009;150:199-205.
  • 49
    Curiel-Lewandrowski C, Chen SC, Swetter SM;Melanoma Prevention Working Group-Pigmented Skin Lesion Sub-Committee. Screening and prevention measures for melanoma: is there a survival advantage? Curr Oncol Rep. 2012;14:458-467.
  • 50
    Oliveria SA, Christos PJ, Marghoob AA, Halpern AC. Skin cancer screening and prevention in the primary care setting: National Ambulatory Medical Care Survey 1997. J Gen Intern Med. 2001;16:297-301.
  • 51
    Yarnall KSH, Pollak KI, Ostbye T, Krause KM, Michener JL. Primary care: is there enough time for prevention? Am J Public Health. 2003;93:635-641.
  • 52
    Davis K, Haisfield L, Dorfman C, Krist A, Taylor KL. Physicians' attitudes about shared decision making for prostate cancer screening. Fam Med. 2011;43:260-266.
  • 53
    Nekhlyudov L, Braddock CH 3rd. An approach to enhance communication about screening mammography in primary care. J Womens Health (Larchmt). 2009;18:1403-1412.
  • 54
    Geller AC, O'Riordan DL, Olilveria SA, Valvo S, Teich M, Halpern AC. Overcoming obstacles to skin cancer examinations and prevention counseling for high-risk patients: results of a national survey of primary care physicians. J Am Board Fam Pract. 2004;17:416-423.
  • 55
    Oliveria SA, Heneghan MK, Cushman LF, Ughetta EA, Halpern AC. Skin cancer screening by dermatologists, family practitioners, and internists: barriers and facilitating factors. Arch Dermatol. 2011;147:39-44.
  • 56
    Redelmeier DA, Tan SH, Booth GL. The treatment of unrelated disorders in patients with chronic medical diseases. N Engl J Med. 1998;338:1516-1520.
  • 57
    Office on Smoking and Health,Centers for Disease Control and Prevention (CDC). Surgeon General's Reports on Smoking and Tobacco Use. Atlanta, GA: CDC; 2004. Available at: http://www.cdc.gov/tobacco/data_statistics/sgr/2004/. Accessed April 12, 2013.
  • 58
    Soriano JB, Visick GT, Muellerova H, Payvandi N, Hansell AL. Patterns of comorbidities in newly diagnosed COPD and asthma in primary care. Chest. 2005;128:2099-2107.
  • 59
    Covey LS, Glassman AH, Stetner F. Cigarette smoking and major depression. J Addict Dis. 1998;17:35-46.
  • 60
    Vogt F, Hall S, Marteau TM. General practitioners' and family physicians' negative beliefs and attitudes towards discussing smoking cessation with patients: a systematic review. Addiction. 2005;100:1423-1431.
  • 61
    Wood ME, Flynn BS, Stockdale A. Primary care physician management, referral, and relations with specialists concerning patients at risk for cancer due to family history. Public Health Genomics. 2013;16:75-82.
  • 62
    Iglehart JK. Expanding the role of advanced nurse practitioners—risks and rewards. N Engl J Med. 2013;368:1935-1941.
  • 63
    Donelan K, DesRoches CM, Dittus RS, Buerhaus P. Perspectives of physicians and nurse practitioners on primary care practice. N Engl J Med. 2013;368:1898-1906.
  • 64
    Dil MJ, Pankow S, Erikson C, Shipman S. Survey shows consumers open to a greater role for physician assistants and nurse practitioners. Health Aff (Millwood). 2013;32:1135-1142.
  • 65
    Allison JE, Potter MB. New screening guidelines for colorectal cancer: a practical guide for the primary care physician. Prim Care. 2008;36:575-602.